<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00299910</url>
  </required_header>
  <id_info>
    <org_study_id>sor388505ctil</org_study_id>
    <nct_id>NCT00299910</nct_id>
  </id_info>
  <brief_title>Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing</brief_title>
  <official_title>Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soroka University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Soroka University Medical Center</source>
  <brief_summary>
    <textblock>
      This study will assess in a double blind placebo controlled fashion the effects of a 12 week
      course of oral montelukast/placebo on polysomnographic and radiological findings and will
      characterize the systemic (serum,urine) and local (upper airway collected biological samples)
      inflammatory response in children (2-10 years of age) with sleep disordered breathing,
      fittingthe inclusion and exclusion criteria.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2005</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Sleep Disordered Breathing</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Montelukast</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:2-10 years old

        1&lt;AHI&lt;8 measured in an overnight PSG

        Exclusion Criteria:

        Asthma Previous use or allergy to montelukast Use of antibiotics in the previous 3 weeks
        Use of corticosteroids in the previous 3 months Craniofacial dysmorphism Genetic or
        metabolic defined illnesses Adenotonsillectomy or adenoidectomy in the past
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Asher Tal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soroka University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aviv D Goldbart, MD, MSc</last_name>
    <phone>972-8-6403400</phone>
    <email>avivgold@bgu.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pediatric Sleep Center, Soroka University Medical Center</name>
      <address>
        <city>Beer-Sheva</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aviv D Goldbart, MD, MSc</last_name>
      <phone>972-8-6403400</phone>
      <email>avivgold@bgu.ac.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005 Aug 1;172(3):364-70. Epub 2005 May 5.</citation>
    <PMID>15879419</PMID>
  </reference>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2006</study_first_submitted>
  <study_first_submitted_qc>March 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2006</study_first_posted>
  <last_update_submitted>May 20, 2008</last_update_submitted>
  <last_update_submitted_qc>May 20, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2008</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Montelukast</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

